We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

High-Definition Volume-Rendering Software Improves Ease-of-Integration, Time-to-Market

By MedImaging International staff writers
Posted on 31 Dec 2014
Print article
Image: Fovia’s high-definition volume-rendering (HDVR) is a CPU-based, advanced visualization technology platform designed for OEMs. The CPU-based technology provides critical information “on-the-fly” via the cloud, local networks, or as an integrated component of existing architectures (Photo courtesy of Fovia).
Image: Fovia’s high-definition volume-rendering (HDVR) is a CPU-based, advanced visualization technology platform designed for OEMs. The CPU-based technology provides critical information “on-the-fly” via the cloud, local networks, or as an integrated component of existing architectures (Photo courtesy of Fovia).
New high-definition volume rendering (HDVR) software provides the ease-of-integration and quick time-to-market required in the current fast-paced imaging environment.

Fovia Medical, Inc. (Palo Alto, CA, USA), a developer of volume-rendering technology, presented an expanded high-definition volume-rendering (HDVR) software range, featuring F.A.S.T. HDVR, at the 100th scientific assembly and annual meeting of the Radiological Society of North America (RSNA), held November 30 to December 5, 2014 , in Chicago (IL, USA). Original equipment manufacturers (OEMs) can utilize central processing unit (CPU)-based F.A.S.T. HDVR to enhance their visualization rapidly and cost-effectively.

F.A.S.T. HDVR provides excellent quality, performance, and scalability for rendering real-time, high-fidelity two-dimensional (2-D), 3-D, 4-D, and 5-D anytime, anywhere. Fovia’s fully customizable OEM product range includes: F.A.S.T. HDVR Web-Zero footprint HTML5 viewer; F.A.S.T. HDVR Vision, a distributable turnkey application; F.A.S.T. HDVR SDK, which is a native integration toolkit; F.A.S.T. HDVR RapidPrint high-fidelity 3D printing ; F.A.S.T. HDVR Mobile3D for mobile devices; and F.A.S.T. HDVR Stereo immersive virtual reality.

The HDVR software enables advanced diagnostic applications, custom workflows and high-performance interactive imaging. Fovia provides a flexible, long-term solution for enterprise-wide or cloud-based deployment.

“Incorporating the gold standard in imaging by integrating F.A.S.T. HDVR improves overall product workflows and enhances patient outcomes,” said David Wilkins, vice president, business development, Fovia. “OEMs are able to maintain the functionality of their existing product line via a F.A.S.T. HDVR integration, and stay in control of their development timeline with bespoke customization, turn-key solutions and multidimensional scalability. Whether it’s for an enterprise-wide, multi-facility network, a stand-alone workstation or a cloud-based mobile platform, F.A.S.T. HDVR delivers the quality, performance, and flexibility needed in today’s market.”

Related Links:

Fovia Medical


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Brachytherapy Planning System
Oncentra Brachy
New
X-Ray QA Meter
Piranha CT
New
Breast Imaging Workstation
SecurView

Print article

Channels

Ultrasound

view channel
Image: The AI-powered Point Of Care Assisted Diagnosis (POCAD) solution is transforming the medical ultrasound industry (Photo courtesy of AISAP)

First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity

Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more